Governments often regulate prices (e.g., capping drug prices or taxing unhealthy goods) to achieve policy goals. But what happens when firms respond strategically? In our new Management Science paper, we study how pharma firms adjust promotions under the 340b Program.

The FTC's case against PepsiCo highlights how promotional payments can give big-box retailers an unfair advantage. My research shows that side payments are just as important as wholesale price discounts in supplier negotiations. #FTC #EconSky

Thrilled to be working with @jurawho.bsky.social and @leofeler.com on such an important topic! The paper documents how purchasing patterns change with adoption of GLP-1 medications, exploring changes across key dimensions like motivation, age, and income.